Carglumic Acid

Carglumic Acid

SCHEMBL373546

NC(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CPS1

The experimentally established mechanism targets of Carglumic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 7/20 0.69
NAALAD2 Q9Y3Q0 5/20 0.69
RIMKLA Q8IXN7 1/20 0.69
GNPAT O15228 1/20 0.49
GGH Q92820 1/20 0.48
CA2 P00918 2/20 0.47
CA1 P00915 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carglumic Acid SCHEMBL910483 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL910527 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27983953 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27983952 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27786751 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27772980 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL28084488 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27786752 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27873856 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAGNPATGGH
Carglumic Acid SCHEMBL27890153 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAGNPATGGH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1552 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4649317-A2 METHODS AND COMPOSITIONS FOR SCREENING AND TREATING ALZHEIMER'S DISEASE Population Bio, Inc. (US) 2025-11-19 EP claimed
EP-4637741-A1 HOMOGENOUSLY SPLITTABLE TABLET COMPOSITIONS COMPRISING CARGLUMIC ACID Santa Farma Ilac Sanayii A.S. (TR) 2025-10-29 EP claimed
US-20250281517-A1 SENOLYSIS BY AMMONIA-LOWERING COMPONENT Taz Inc. (JP) 2025-09-11 US claimed
EP-4110756-B1 PROCESS FOR THE PURIFICATION OF CARGLUMIC ACID AND INTERMEDIATE OF THIS PROCESS SCALE UP LABORATORY S R O (CZ) 2025-08-13 EP claimed
CN-120188854-A Nutritional feed based on urea and application of nutritional feed in ruminants 云南牛牛牧业股份有限公司 2025-06-24 CN claimed
CN-119524462-B Processing equipment and processing technology for N-carbamylglutamic acid 锦州医科大学 2025-06-13 CN claimed
CN-119999817-A Sheep feed based on silage tea leaves and preparation method and application thereof 浙江工商大学 2025-05-16 CN claimed
CN-119404781-B Bionic artificial propagation method for Dongxingqi 海南晨海水产有限公司 2025-04-15 CN claimed
CN-119524462-A Processing equipment and processing technology for NCG 锦州医科大学 2025-02-28 CN claimed
CN-119523022-A Nutritional additive for preventing and relieving livestock transportation stress and application thereof 内蒙古自治区农牧业科学院 2025-02-28 CN claimed
CN-101565385-A Pigling intestinal tract nutrition regulation and control substance N-carbamoylglutamine and preparation method INST SUBTROPICAL AGRICULTUR (CN) 2009-10-28 CN claimed
CN-101481336-A Preparation of N-carbamoyl-aminoglutaric acid and sodium salt thereof UNIV NANCHANG (CN) 2009-07-15 CN claimed
WO-2008116165-A9 METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION NEXT SAFETY INC (US) 2009-06-11 WO claimed
CN-101440042-A Preparation of N-carbamylglutamic BEIJING LONGKE FANGZHOU BIOLOG (CN) 2009-05-27 CN claimed
WO-2008116165-A2 METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION NEXT SAFETY, INC. (US) 2008-09-25 WO claimed
CN-101168518-A Method for preparing N-carbamyl glutamic acid YULONG YIN (CN) 2008-04-30 CN claimed
US-20070036841-A1 Method of enhancing an ornithine-urea cycle in ruminant gut tissues to detoxify ammonia and increase local urea recycling to the rumen for microbial protein synthesis BEQUETTE BRIAN JAMES 2007-02-15 US claimed
US-7157497-B2 Method of enhancing an ornithine-urea cycle in ruminant gut tissues to detoxify ammonia and increase local urea recycling to the rumen for microbial protein synthesis UNIVERSITY OF MARYLAND 2007-01-02 US claimed
US-20040258736-A1 Method of enhancing an ornithine-urea cycle in ruminant gut tissues to detoxify ammonia and increase local urea recycling to the rumen for microbial protein synthesis UNIVERSITY OF MARYLAND 2004-12-23 US claimed
EP-1209234-A1 STEREOSTRUCTURE OF DECARBAMYLASE AND METHOD OF USING THE SAME Kaneka Corporation (JP) 2002-05-29 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040258736-A1 Method of enhancing an ornithine-urea cycle in ruminant gut tissues to detoxify ammonia and increase local urea recycling to the rumen for microbial protein synthesis OAT, OTC, ODC1 FOLH1 881/4885NAALAD2 481/4885RIMKLA 116/4885
US-20070036841-A1 Method of enhancing an ornithine-urea cycle in ruminant gut tissues to detoxify ammonia and increase local urea recycling to the rumen for microbial protein synthesis OAT, OTC, ODC1 FOLH1 881/4885NAALAD2 481/4885RIMKLA 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.